全球即时诊断市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，即时诊断市场规模将从 2025 年的 497 亿美元成长至 825.5 亿美元，2026 年至 2034 年的复合年增长率为 5.8%。

由于对快速、分散式检测解决方案的需求不断增长，全球照护现场诊断市场正经历显着成长。照护现场设备可在患者所在位置或附近提供即时诊断结果，从而改善治疗决策并缩短住院时间。感染疾病、糖尿病和心血管疾病的日益普及推动了对携带式诊断工具的需求。

关键成长要素包括微型化和生物感测器技术的进步。急诊室、居家医疗机构和社区诊所的广泛应用也推动了市场成长。新冠疫情加速了全球对快速检测解决方案的认知和应用。政府为促进医疗保健服务的可近性而采取的措施也促进了市场成长。

展望未来，分子诊断技术和智慧型手机互联检测设备的创新将拓展其应用领域。个人化医疗和预防医学的发展将持续支持市场需求。新兴市场对医疗基础建设的投资也蕴藏着巨大的机会。随着医疗保健向便捷快速诊断的方向发展，照护现场仍将是现代临床医学的核心。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球即时诊断市场：依产品划分

• 市场分析、洞察与预测
• 血糖监测
• 传染病检查
• 心血管代谢疾病检测
• 妊娠和不孕症检查
• 验血
• 其他的

第五章 全球即时诊断市场：依检体划分

• 市场分析、洞察与预测
• 血
• 鼻拭子和口咽拭子
• 尿
• 其他的

第六章 全球即时诊断市场：依最终用户划分

• 市场分析、洞察与预测
• 医院床边
• 诊所内的医生检查室
• 急诊诊所和零售诊所
• 家庭使用/自测

第七章 全球即时诊断市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • EKF Diagnostics Holdings Plc
  • Cardinal HealthInc
  • Thermo Fisher Scientific Inc
  • Quest Diagnostics Incorporated
  • BD
  • BioMerieux SA
  • QuidelOrtho Corporation
  • Bio-Rad Laboratories Inc

The Point Of Care Diagnostics Market size is expected to reach USD 82.55 Billion in 2034 from USD 49.70 Billion (2025) growing at a CAGR of 5.8% during 2026-2034.

The Global Point of Care Diagnostics Market has experienced substantial growth due to increasing demand for rapid and decentralized testing solutions. Point-of-care devices enable immediate diagnostic results at or near the patient site, improving treatment decisions and reducing hospital stays. Rising prevalence of infectious diseases, diabetes, and cardiovascular conditions has fueled demand for portable diagnostic tools.

Major growth drivers include technological advancements in miniaturization and biosensor technologies. Increasing adoption in emergency rooms, home healthcare settings, and rural clinics supports market expansion. The pandemic accelerated awareness and deployment of rapid testing solutions globally. Government initiatives promoting accessible healthcare services further contribute to growth.

Looking forward, innovation in molecular diagnostics and smartphone-integrated testing devices will expand application areas. Growth in personalized medicine and preventive healthcare will sustain demand. Emerging economies investing in healthcare infrastructure provide strong opportunities. As healthcare shifts toward convenience and faster diagnosis, point-of-care diagnostics will remain central to modern clinical practices.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Blood Glucose Monitoring
• Infectious Disease Testing
• Cardiometabolic Disease Testing
• Pregnancy & Fertility Testing
• Hematology Testing
• Others

By Sample

• Blood
• Nasal and Oropharyngeal Swabs
• Urine
• Others

By End-User

• Hospital Bedside
• Physician's Office Lab
• Urgent Care & Retail Clinics
• Home & Self testing

COMPANIES PROFILED

• F HoffmannLa Roche Ltd, Abbott, EKF Diagnostics Holdings plc, Cardinal Health, Inc, Thermo Fisher Scientific Inc, Quest Diagnostics Incorporated, BD, bioMerieux SA, QuidelOrtho Corporation, BioRad Laboratories Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POINT OF CARE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Blood Glucose Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infectious Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cardiometabolic Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Pregnancy & Fertility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Hematology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POINT OF CARE DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample
• 5.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Nasal and Oropharyngeal Swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POINT OF CARE DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospital Bedside Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Physician's Office Lab Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Urgent Care & Retail Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Home & Self testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POINT OF CARE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Sample
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Sample
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Sample
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Sample
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Sample
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POINT OF CARE DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 F. Hoffmann-La Roche Ltd
  • 9.2.2 Abbott
  • 9.2.3 EKF Diagnostics Holdings Plc
  • 9.2.4 Cardinal HealthInc
  • 9.2.5 Thermo Fisher Scientific Inc
  • 9.2.6 Quest Diagnostics Incorporated
  • 9.2.7 BD
  • 9.2.8 BioMerieux SA
  • 9.2.9 QuidelOrtho Corporation
  • 9.2.10 Bio-Rad Laboratories Inc